EJMC-1

CAS No. 397281-20-8

EJMC-1( N-(3-chloro-4-hydroxyphenyl)-2-oxo-1,2-dihydrobenzo[cd]indole-6-sulfonamide )

Catalog No. M28517 CAS No. 397281-20-8

EJMC-1 is an inhibitor of TNF-α with an IC50 value of 42 μM and can be used in studies about auto-inflammatory diseases.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 211 In Stock
10MG 300 In Stock
25MG 438 In Stock
50MG 586 In Stock
100MG 792 In Stock
200MG 1070 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    EJMC-1
  • Note
    Research use only, not for human use.
  • Brief Description
    EJMC-1 is an inhibitor of TNF-α with an IC50 value of 42 μM and can be used in studies about auto-inflammatory diseases.
  • Description
    EJMC-1 is an inhibitor of TNF-α with an IC50 value of 42 μM and can be used in studies about auto-inflammatory diseases.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    N-(3-chloro-4-hydroxyphenyl)-2-oxo-1,2-dihydrobenzo[cd]indole-6-sulfonamide
  • Pathway
    Apoptosis
  • Target
    TNF
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    397281-20-8
  • Formula Weight
    374.8
  • Molecular Formula
    C17H11ClN2O4S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 125 mg/mL (333.51 mM)
  • SMILES
    Oc1ccc(NS(=O)(=O)c2ccc3NC(=O)c4cccc2c34)cc1Cl
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • XYLOBIOSE

    XYLOBIOSE ia a natural productand exhibited therapeutic potential for treating obesity which involved suppression of fat deposition and obesity-related metabolic disorders.

  • Atibuclimab

    Atibuclimab is a chimeric monoclonal antibody targeting CD14, consisting of a mouse variable region and a human IgG4 Fc region.

  • Trilobatin

    Trilobatin has anti-oxidant effect can increase superoxide dismutase (SOD) activity.Trilobatin has anti-inflammatory effect it potentially inhibits the lipopolysaccharide (LPS)-induced inflammatory response by suppressing the NF-κB signaling pathway.